GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Personal Services » Grey Wolf Animal Health Corp (TSXV:WOLF) » Definitions » ROE %

Grey Wolf Animal Health (TSXV:WOLF) ROE % : 7.70% (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Grey Wolf Animal Health ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Grey Wolf Animal Health's annualized net income for the quarter that ended in Sep. 2024 was C$2.01 Mil. Grey Wolf Animal Health's average Total Stockholders Equity over the quarter that ended in Sep. 2024 was C$26.07 Mil. Therefore, Grey Wolf Animal Health's annualized ROE % for the quarter that ended in Sep. 2024 was 7.70%.

The historical rank and industry rank for Grey Wolf Animal Health's ROE % or its related term are showing as below:

TSXV:WOLF' s ROE % Range Over the Past 10 Years
Min: -23.77   Med: 2.47   Max: 17.96
Current: 3.61

During the past 3 years, Grey Wolf Animal Health's highest ROE % was 17.96%. The lowest was -23.77%. And the median was 2.47%.

TSXV:WOLF's ROE % is ranked worse than
60.2% of 98 companies
in the Personal Services industry
Industry Median: 5.575 vs TSXV:WOLF: 3.61

Grey Wolf Animal Health ROE % Historical Data

The historical data trend for Grey Wolf Animal Health's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grey Wolf Animal Health ROE % Chart

Grey Wolf Animal Health Annual Data
Trend Dec21 Dec22 Dec23
ROE %
-23.77 17.96 2.47

Grey Wolf Animal Health Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.50 -4.51 2.00 9.07 7.70

Competitive Comparison of Grey Wolf Animal Health's ROE %

For the Personal Services subindustry, Grey Wolf Animal Health's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grey Wolf Animal Health's ROE % Distribution in the Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Grey Wolf Animal Health's ROE % distribution charts can be found below:

* The bar in red indicates where Grey Wolf Animal Health's ROE % falls into.



Grey Wolf Animal Health ROE % Calculation

Grey Wolf Animal Health's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=0.61/( (24.247+25.09)/ 2 )
=0.61/24.6685
=2.47 %

Grey Wolf Animal Health's annualized ROE % for the quarter that ended in Sep. 2024 is calculated as

ROE %=Net Income (Q: Sep. 2024 )/( (Total Stockholders Equity (Q: Jun. 2024 )+Total Stockholders Equity (Q: Sep. 2024 ))/ count )
=2.008/( (25.803+26.341)/ 2 )
=2.008/26.072
=7.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2024) net income data. ROE % is displayed in the 30-year financial page.


Grey Wolf Animal Health  (TSXV:WOLF) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=2.008/26.072
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(2.008 / 27.596)*(27.596 / 39.7935)*(39.7935 / 26.072)
=Net Margin %*Asset Turnover*Equity Multiplier
=7.28 %*0.6935*1.5263
=ROA %*Equity Multiplier
=5.05 %*1.5263
=7.70 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Sep. 2024 )
=Net Income/Total Stockholders Equity
=2.008/26.072
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (2.008 / 2.912) * (2.912 / 3.208) * (3.208 / 27.596) * (27.596 / 39.7935) * (39.7935 / 26.072)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.6896 * 0.9077 * 11.62 % * 0.6935 * 1.5263
=7.70 %

Note: The net income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Grey Wolf Animal Health ROE % Related Terms

Thank you for viewing the detailed overview of Grey Wolf Animal Health's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Grey Wolf Animal Health Business Description

Traded in Other Exchanges
N/A
Address
100 King Street West, Suite 6000, 1 First Canadian Place,, Toronto, ON, CAN, M5X 1E2
Grey Wolf Animal Health Corp operates as an animal health company. It focuses on improving the lives and well-being of vets and pets in Canada. It has two reportable operating segments: the Animal Health business unit selling, marketing, and distributing pharmaceutical, nutraceutical, and consumable products to veterinary clinics across Canada. and the Pharmacy business unit compounds pharmaceuticals, for equine use but also the bio-identical hormone replacement therapy market, all based on prescriptions received from veterinarians, physicians, and patients.
Executives
Angela Cechetto Senior Officer
Diane Bourassa Director
Shawn Douglas Aspden Director
Jill Terilee Angevine Director

Grey Wolf Animal Health Headlines

From GuruFocus